The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long‐term follow‐up and genetic analysis

2019 ◽  
Vol 30 (4) ◽  
pp. 469-478 ◽  
Author(s):  
Mahmood Tavassoli ◽  
Hassan Abolhassani ◽  
Reza Yazdani ◽  
Mohsen Ghadami ◽  
Gholamreza Azizi ◽  
...  
Blood ◽  
2004 ◽  
Vol 104 (10) ◽  
pp. 3086-3090 ◽  
Author(s):  
Teal S. Hallstrand ◽  
Jay D. Sprenger ◽  
Jan M. Agosti ◽  
Gary M. Longton ◽  
Robert P. Witherspoon ◽  
...  

Abstract Adoptive transfer of allergen-specific immunoglobulin E (IgE) from atopic donors to nonatopic recipients occurs during the first year following bone marrow transplantation (BMT). Mature B- and T-cell clones with allergen-specific memory and hematopoietic progenitor cells are transferred through BMT. The objective of this study was to characterize the long-term rate of allergic sensitization and development of clinical allergic diseases following BMT from atopic donors. A long-term follow-up study was conducted in a cohort of donor and recipient pairs with moderate-to-severe allergic disease in the donor prior to BMT. Assessments of allergen-specific IgE, clinical rhinitis, and asthma were made in the donors prior to BMT and in the recipients with a mean follow-up of 15.5 years after BMT. From an initial cohort of 12 bone marrow transplant recipients who received marrow from allergic donors, 5 long-term survivors were identified. Allergen-specific IgE transferred from donor to recipient following BMT frequently persisted, and a high rate of de novo allergic sensitization was observed between 1 and 14 years after BMT. These events were associated with elevation in total IgE, and development of allergic rhinitis and asthma at long-term follow-up. We conclude that marrow-derived immune cells from allergic donors can transfer the predisposition to allergy and asthma.


2018 ◽  
Vol 21 (8) ◽  
pp. 1627-1633 ◽  
Author(s):  
Mehrzad Hajialilo ◽  
Amir Ghorbanihaghjo ◽  
Alireza Khabbazi ◽  
Sousan Kolahi ◽  
Mohammad Reza Jafari Nakhjavani ◽  
...  

2016 ◽  
Vol 44 (4) ◽  
pp. 322-330 ◽  
Author(s):  
M. Nabavi ◽  
S. Arshi ◽  
M.H. Bemanian ◽  
A. Aghamohammadi ◽  
D. Mansouri ◽  
...  

2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.


2001 ◽  
Vol 120 (5) ◽  
pp. A397-A397
Author(s):  
M SAMERAMMAR ◽  
J CROFFIE ◽  
M PFEFFERKORN ◽  
S GUPTA ◽  
M CORKINS ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A204-A204
Author(s):  
B GONZALEZCONDE ◽  
J VAZQUEZIGLESIAS ◽  
L LOPEZROSES ◽  
P ALONSOAGUIRRE ◽  
A LANCHO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document